Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert Bader

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Investigative Medicine High Impact Case Reports|February 27, 2019
Concurrent JAK2-Positive Myeloproliferative Disorder and Chronic Myelogenous Leukemia: A Novel Entity? A Case Report With Review of the LiteratureGilbert Bader, Bernard Dreiling
The Journal of Community and Supportive Oncology|February 13, 2016
Thyroid nodule: not as clear-cut as it seemsGilbert Bader, Igor Puzanov, Kanishka Chakraborty
Surgical Infections|August 12, 2016
Review of Prosthetic Joint Infection from Listeria monocytogenesGilbert Bader, Mohammed Al-Tarawneh, James Myers
The American Journal of Case Reports|June 28, 2016
Successful Treatment of Pyoderma Gangrenosum with Cryoglobulinemia and Hepatitis CMohsen Pourmorteza, Fady Tawadros, Gilbert Bader, et al.
Breast Cancer Research and Treatment|May 30, 2025
Utility of plasma circulating DNA tumor fraction in bone-only metastatic breast cancer: a real-world outcomes studyGilbert Bader, Julia C F Quintanilha, Deloris Veney, et al.
Frontiers in Oncology|May 25, 2026
Management of bone metastases in patients with breast cancer: review of bone-modifying therapy, emerging new agents, and future directionsGilbert Bader, Brianna Brown, Ashley Pariser Davenport, et al.
Frontiers in Oncology|April 10, 2026
Case Report: Late choroidal metastasis from hormone receptor-positive, HER2-negative breast cancer responsive to first-line endocrine therapyHisham Alsharif, Robert Wesolowski, Colleen M Cebulla, et al.
JACC. Case Reports|May 9, 2025
Pembrolizumab-Induced Smoldering Myocarditis in Patients With Triple-Negative Breast CancerAdnan Shaaban, Alma Habib, Dionisia Quiroga, et al.
Cancer Control : Journal of the Moffitt Cancer Center|May 4, 2026
Denosumab as Second-Line Treatment in Patients With Metastatic Breast Cancer: A Retrospective Descriptive Pilot Study From a Single InstitutionBriana To, Laura E Wright, Dureti Doto, et al.
The Oncologist|July 16, 2026
Impact of Oncotype DX Risk Categorization and Receipt of Chemotherapy on Survival Outcomes Among Patients with Small Node-Negative HR+ Breast CancerAndrea House, Julie A Stephens, Robert Wesolowski, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Investigative Medicine High Impact Case Reports|February 27, 2019
Concurrent JAK2-Positive Myeloproliferative Disorder and Chronic Myelogenous Leukemia: A Novel Entity? A Case Report With Review of the LiteratureGilbert Bader, Bernard Dreiling
The Journal of Community and Supportive Oncology|February 13, 2016
Thyroid nodule: not as clear-cut as it seemsGilbert Bader, Igor Puzanov, Kanishka Chakraborty
Surgical Infections|August 12, 2016
Review of Prosthetic Joint Infection from Listeria monocytogenesGilbert Bader, Mohammed Al-Tarawneh, James Myers
The American Journal of Case Reports|June 28, 2016
Successful Treatment of Pyoderma Gangrenosum with Cryoglobulinemia and Hepatitis CMohsen Pourmorteza, Fady Tawadros, Gilbert Bader, et al.
Breast Cancer Research and Treatment|May 30, 2025
Utility of plasma circulating DNA tumor fraction in bone-only metastatic breast cancer: a real-world outcomes studyGilbert Bader, Julia C F Quintanilha, Deloris Veney, et al.
Frontiers in Oncology|May 25, 2026
Management of bone metastases in patients with breast cancer: review of bone-modifying therapy, emerging new agents, and future directionsGilbert Bader, Brianna Brown, Ashley Pariser Davenport, et al.
Frontiers in Oncology|April 10, 2026
Case Report: Late choroidal metastasis from hormone receptor-positive, HER2-negative breast cancer responsive to first-line endocrine therapyHisham Alsharif, Robert Wesolowski, Colleen M Cebulla, et al.
JACC. Case Reports|May 9, 2025
Pembrolizumab-Induced Smoldering Myocarditis in Patients With Triple-Negative Breast CancerAdnan Shaaban, Alma Habib, Dionisia Quiroga, et al.
Cancer Control : Journal of the Moffitt Cancer Center|May 4, 2026
Denosumab as Second-Line Treatment in Patients With Metastatic Breast Cancer: A Retrospective Descriptive Pilot Study From a Single InstitutionBriana To, Laura E Wright, Dureti Doto, et al.
The Oncologist|July 16, 2026
Impact of Oncotype DX Risk Categorization and Receipt of Chemotherapy on Survival Outcomes Among Patients with Small Node-Negative HR+ Breast CancerAndrea House, Julie A Stephens, Robert Wesolowski, et al.
Pageof 1